Docetaxel and Thalidomide as a Treatment Option for Androgen- Independent, Nonmetastatic Prostate Cancer

Prostate cancer usually presents with early-stage disease, yet a significant proportion of patients present or will progress to androgen-independent, nonmetastatic prostate cancer (AIPC). Chemotherapy has demonstrated statistically significant improvements in palliation of AIPC. Docetaxel in particu...

Full description

Saved in:
Bibliographic Details
Main Authors: Leonard, Gregory D, Dahut, William L, Gulley, James L, Arlen, Philip M, Figg, William D
Format: Artigo
Language:Inglês
Published: MedReviews, LLC 2003
Subjects:
Optimizing Treatment for Advanced Prostate Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1502338/
https://ncbi.nlm.nih.gov/pubmed/16985953
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items